Nanjiang Hou
Overview
Explore the profile of Nanjiang Hou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
319
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang S, Gozansky W, Steiner C, Lee J, Nguyen A, Shen E, et al.
J Palliat Med
. 2024 Mar;
27(5):602-613.
PMID: 38483344
Gaps remain in our understanding of the intensity and timing of specialty palliative care (SPC) exposure on end-of-life (EOL) outcomes. Examine the association between intensity and timing of SPC and...
2.
Bavinger C, Bendavid E, Niehaus K, Olshen R, Olkin I, Sundaram V, et al.
PLoS One
. 2013 Apr;
8(3):e59551.
PMID: 23555704
Background: Recent studies suggest certain antiretroviral therapy (ART) drugs are associated with increases in cardiovascular disease. Purpose: We performed a systematic review and meta-analysis to summarize the available evidence, with...
3.
Morrow M, Chatterton Jr R, Rademaker A, Hou N, Jordan V, Hendrick R, et al.
Breast Cancer Res Treat
. 2009 Aug;
121(3):565-74.
PMID: 19669673
Mammographic breast density has been proposed as a surrogate endpoint in breast cancer prevention studies, but little is known about its variability over time, particularly in relation to menstrual cycle...
4.
Khan S, Lankes H, Patil D, Bryk M, Hou N, Ivancic D, et al.
Cancer Prev Res (Phila)
. 2009 Feb;
2(3):265-73.
PMID: 19223577
Effective methods of serial epithelial sampling to measure breast-specific biomarkers will aid the rapid evaluation of new preventive interventions. We report here a proof-of-principle phase 2 study to assess the...
5.
Evens A, Winter J, Hou N, Nelson B, Rademaker A, Patton D, et al.
Br J Haematol
. 2007 Dec;
140(4):385-93.
PMID: 18162124
Mantle cell lymphoma (MCL) is associated with high relapse rates and poor survival when treated with conventional chemotherapy, with or without rituximab. We report the long-term follow-up of a phase...
6.
Patil D, Lankes H, Nayar R, Masood S, Bryk M, Hou N, et al.
Breast Cancer Res Treat
. 2007 Dec;
112(2):327-33.
PMID: 18097749
Background: Ductal lavage (DL) allows repeat sampling of breast epithelium for serial observation in a chemoprevention setting; however, the reproducibility of duct cannulation, cell yield and cytology has not been...
7.
Evens A, Cilley J, Ortiz T, Gounder M, Hou N, Rademaker A, et al.
Br J Haematol
. 2007 Apr;
137(6):545-52.
PMID: 17459049
Dose-intensity of chemotherapy is important in the treatment of Hodgkin lymphoma (HL) and granulocyte-colony stimulating factor (G-CSF) is commonly used to maintain it. We reviewed all newly diagnosed HL patients...
8.
Bhandare D, Nayar R, Bryk M, Hou N, Cohn R, Golewale N, et al.
Cancer Epidemiol Biomarkers Prev
. 2005 Nov;
14(11 Pt 1):2620-7.
PMID: 16284387
Background: Ductal lavage is a method of minimal epithelial sampling of the breast, with potential utility for repeat sampling and biomarker analysis in chemoprevention studies. We report here the baseline...
9.
Nakhlis F, Lazarus L, Hou N, Acharya S, Khan S, Staradub V, et al.
J Am Coll Surg
. 2005 Nov;
201(5):688-94.
PMID: 16256910
Background: The purpose of this study was to determine how often patients with ductal carcinoma in situ and T1a/b N0 cancer are offered and accept tamoxifen for secondary chemoprevention. Study...
10.
Chatterton Jr R, Mateo E, Hou N, Rademaker A, Acharya S, Jordan V, et al.
J Endocrinol
. 2005 Jul;
186(1):77-84.
PMID: 16002538
The objective of the study was to characterize salivary sex steroid levels in 56 women undergoing annual mammography who were participating in a breast density study at the Lynn Sage...